Treatment of older persons by statines;Statines et risque cérébro- et cardiovasculaire chez les personnes âgées

Revue de Medecine Interne

Volumn 25, Issue 11, 2004, Pages 801-805

  Schlienger, J L ^a   Vinzio, S ^a   Pradignac, A ^a   Grunenberger, F ^a   Goichot, B ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Cardiovascular diseases; Elderly; Hypercholesterolemia; Statins

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; STATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; MORTALITY; REVIEW; SIDE EFFECT; STROKE; AGED; ALGORITHM; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; RANDOMIZED CONTROLLED TRIAL;

AGED; ALGORITHMS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS;

EID: 14344250849     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.01.013     Document Type: Short Survey

References (25)

1. Anderson K.M., Castelli W.P., Levy D. Cholesterol and mortality; 30 years follow-up from the Framingham study. JAMA. 257:1987;2176-2180
2. Byington R.P., Davis B.R., Plehn J.F., White H.D., Baker J., Cobe S.M., Schepherd J. Reduction of stroke events with pravastatin. The Prospective Pravastatin Pooling (PPP) project. Circulation. 103:2001;387-1312
3. Forette B., Tortrat D., Wolmark Y. Cholesterol and mortality in elderly women. Lancet. 1:1989;868-870
4. Schlienger J.L. La controverse du cholestérol. Presse Med. 24:1995;471-473
5. Weverling-Rijnsburger A.W.E., Blauw G.J., Lagaay A.M., Knook D.L., Meinders A.E., Westendorp R.G.J. Total cholesterol and risk of mortality in the oldest old. Lancet. 35:1997;1119-1123
6. Simons L.A., Simons J., Friedlander Y., Mc Callum J. Cholesterol and other lipids predict coronary heart disease and ischemic stroke in the elderly, but only in those below 70 years. Atherosclerosis. 159:2001;201-208
7. Menotti A., Mulder I., Nissinen A., Feskens E., Giampadli S., Tervahauta M., et al. Cardiovascular risk factors and 10 year all cause mortality in elderly European male population. Eur. Heart. J. 22:2001;573-579. The FINE study
8. Hakim A.A., Curb J.D., Burchfiel C.M., Rodriguez B.L., Sharp D.S., Yano K., et al. Screening for coronary heart disease in elderly men based on current and post cholesterol levels. J Clin Epidemiol. 52:1999;1257-1265
9. Ford E.S., Mokdad A.H., Giles W.H., Mensah G.A. Serum total cholesterol concentration and awarenes, treatment and control of hypercholesterolemia among US adult: findings from the National Health and Nutrition Survey 1999 to 2000. Circulation. 107:2000;2185-2189
10. Davignon J., Laaksonen R. Low density lipoprotein - independant effects of statins. Cur Opin Lipidol. 10:1999;543-559
11. Agence française de sécurité sanitaire des produits de santé. Recommandations de bonne pratique: prise en charge thérapeutique du patient dyslipidémique. Septembre 2000
12. Lansberg P.J., Mitchel Y.B., Shapiro D., Kastelein J.J.P., Altman R., Jerums G., et al. Long term efficacy and tolerability of Simvastatin in a large cohort of elderly hypercholesterolemic patients. Atherosclerosis. 116:(2):1995;153-162
13. Chan P., Lee C.B., Ko J.T., Pan W.H., Lee Y.S. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy. Am J Hypert. 8:1995;1099-1104
14. Lewis S.J. Effect of pravastatine on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the cholesterol and recurrent events (CARE) trial. Ann Int Med. 129:1998;681-1668
15. Maycock C.A.A., Muhlenstein J.B., Horne B.D., Carlquist J.F., Bair T.L., Pearson R.R. et al. for the Intermountain Heart Collaborative Study. Statin therapy is associated risk reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol. 40:2002;1777-1785
16. Lemaitre R.N., Psaty B.M., Heckbert S.R., Kronhal R.A., Newman A.B., Burke G.L. Therapy with hydroxymethylgutary Coenzyme A reductase inhibitors (Statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. Arch Int Med. 162:2002;1395-11140
17. Aronow W.S., Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥ 125 mg/dl treated with statin versus no lipid-lowering drug. Am. J. Cardiol. 89:2002;67-69
18. Aronow W.S., Ahn C., Gutstein H. Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > 125mg/dl treated with statins versus no lipid-lowering drug. J Gerontol Med Sci. 57A:2002;M 333-M 335
19. Aronow W.S., Ahn C. Frequency of new coronary events in older persons with periphenal arterial disease and serum low-density lipoprotein ≥ 125 mg/dl treated with statin vs. non lipid-lowering drug. Am J Cardiol. 90:2002;789-791
20. Sheperd J., Blauw G.J., Murphy M.B., Bollen L.E.M., Buckley B.M., Cobbe S.M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 360:2002;1623-1630
21. Aronow W.S. Effects of statin on mortality and cardiovascular events in elderly high-risk persons. J Am Ger Soc. 51:2003;717-718
22. Sever P.S., Björn-Dahlöf, Poulter N.R., Wedel H., Beevers G., Caulkied M., et al. for the Ascot Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid lowering Arm (ASCOT-LLA): a multicenter randomised controlled trial. Lancet. 361:2003;1149-1158
23. Bjerre L.M., Le Lorier J. Do statins cause cancer? A meta-analysis of large randomised clinical trials. Am J Med. 110:2001;716-723
24. Aronow W.S. Rationale for lipid lowering in older patients with or without CAD. Geriatrics. 56:2001;28-30
25. Farnier M. Hyperlipidémies du sujet âgé Presse Med. 30:2001;957-963